Global Liposome Drug Delivery Market Size, Manufacturers, Opportunities and Forecast to 2030
Summary
Liposomes have been used to improve the therapeutic index of new or established drugs by modifying drug absorption, reducing metabolism, prolonging biological half-life or reducing toxicity. Drug distribution is then controlled primarily by properties of the carrier and no longer by physico-chemical characteristics of the drug substance only. In a liposome drug product, the drug substance is contained in liposomes. Typically, water soluble drugs are contained in the aqueous compartment(s) and hydrophobic drugs are contained in the lipid layer(s) of the liposomes. Release of drugs from liposome formulations can be modified by the presence of polyethylene glycol and/or cholesterol or other potential additives in the liposome.
According to APO Research, The global Liposome Drug Delivery market was estimated at US$ million in 2023 and is projected to reach a revised size of US$ million by 2030, witnessing a CAGR of xx% during the forecast period 2024-2030.
North American market for Liposome Drug Delivery is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for Liposome Drug Delivery is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for Liposome Drug Delivery is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global manufacturers of Liposome Drug Delivery include Gilead Sciences, Pacira, Sun Pharmaceutical, Johnson & Johnson, Luye Pharma, Sigma-Tau, Ipsen (Onivyde), CSPC and Teva Pharmaceutical, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Liposome Drug Delivery, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Liposome Drug Delivery.
The Liposome Drug Delivery market size, estimations, and forecasts are provided in terms of sales volume (K Vial) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Liposome Drug Delivery market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Liposome Drug Delivery market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Liposome Drug Delivery and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Liposome Drug Delivery.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, Latin America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Liposome Drug Delivery manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Liposome Drug Delivery in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, Latin America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
Liposomes have been used to improve the therapeutic index of new or established drugs by modifying drug absorption, reducing metabolism, prolonging biological half-life or reducing toxicity. Drug distribution is then controlled primarily by properties of the carrier and no longer by physico-chemical characteristics of the drug substance only. In a liposome drug product, the drug substance is contained in liposomes. Typically, water soluble drugs are contained in the aqueous compartment(s) and hydrophobic drugs are contained in the lipid layer(s) of the liposomes. Release of drugs from liposome formulations can be modified by the presence of polyethylene glycol and/or cholesterol or other potential additives in the liposome.
According to APO Research, The global Liposome Drug Delivery market was estimated at US$ million in 2023 and is projected to reach a revised size of US$ million by 2030, witnessing a CAGR of xx% during the forecast period 2024-2030.
North American market for Liposome Drug Delivery is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for Liposome Drug Delivery is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for Liposome Drug Delivery is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global manufacturers of Liposome Drug Delivery include Gilead Sciences, Pacira, Sun Pharmaceutical, Johnson & Johnson, Luye Pharma, Sigma-Tau, Ipsen (Onivyde), CSPC and Teva Pharmaceutical, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Liposome Drug Delivery, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Liposome Drug Delivery.
The Liposome Drug Delivery market size, estimations, and forecasts are provided in terms of sales volume (K Vial) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Liposome Drug Delivery market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
- Gilead Sciences
- Pacira
- Sun Pharmaceutical
- Johnson & Johnson
- Luye Pharma
- Sigma-Tau
- Ipsen (Onivyde)
- CSPC
- Teva Pharmaceutical
- Novartis
- Fudan-Zhangjiang
- Liposomal Doxorubicin
- Liposomal Amphoteracin B
- Liposomal Paclitaxel
- Others
- Fungal Infection Therapy
- Cancer & Tumor Therapy
- Others
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia
- China Taiwan
- Indonesia
- Thailand
- Malaysia
- Latin America
- Mexico
- Brazil
- Argentina
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Liposome Drug Delivery market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Liposome Drug Delivery and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Liposome Drug Delivery.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, Latin America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Liposome Drug Delivery manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Liposome Drug Delivery in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, Latin America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
1 MARKET OVERVIEW
1.1 Product Definition
1.2 Global Market Growth Prospects
1.2.1 Global Liposome Drug Delivery Market Size Estimates and Forecasts (2019-2030)
1.2.2 Global Liposome Drug Delivery Sales Estimates and Forecasts (2019-2030)
1.3 Liposome Drug Delivery Market by Type
1.3.1 Liposomal Doxorubicin
1.3.2 Liposomal Amphoteracin B
1.3.3 Liposomal Paclitaxel
1.3.4 Others
1.4 Global Liposome Drug Delivery Market Size by Type
1.4.1 Global Liposome Drug Delivery Market Size Overview by Type (2019-2030)
1.4.2 Global Liposome Drug Delivery Historic Market Size Review by Type (2019-2024)
1.4.3 Global Liposome Drug Delivery Forecasted Market Size by Type (2025-2030)
1.5 Key Regions Market Size by Type
1.5.1 North America Liposome Drug Delivery Sales Breakdown by Type (2019-2024)
1.5.2 Europe Liposome Drug Delivery Sales Breakdown by Type (2019-2024)
1.5.3 Asia-Pacific Liposome Drug Delivery Sales Breakdown by Type (2019-2024)
1.5.4 Latin America Liposome Drug Delivery Sales Breakdown by Type (2019-2024)
1.5.5 Middle East and Africa Liposome Drug Delivery Sales Breakdown by Type (2019-2024)
2 GLOBAL MARKET DYNAMICS
2.1 Liposome Drug Delivery Industry Trends
2.2 Liposome Drug Delivery Industry Drivers
2.3 Liposome Drug Delivery Industry Opportunities and Challenges
2.4 Liposome Drug Delivery Industry Restraints
3 MARKET COMPETITIVE LANDSCAPE BY COMPANY
3.1 Global Top Players by Liposome Drug Delivery Revenue (2019-2024)
3.2 Global Top Players by Liposome Drug Delivery Sales (2019-2024)
3.3 Global Top Players by Liposome Drug Delivery Price (2019-2024)
3.4 Global Liposome Drug Delivery Industry Company Ranking, 2022 VS 2023 VS 2024
3.5 Global Liposome Drug Delivery Key Company Manufacturing Sites & Headquarters
3.6 Global Liposome Drug Delivery Company, Product Type & Application
3.7 Global Liposome Drug Delivery Company Commercialization Time
3.8 Market Competitive Analysis
3.8.1 Global Liposome Drug Delivery Market CR5 and HHI
3.8.2 Global Top 5 and 10 Liposome Drug Delivery Players Market Share by Revenue in 2023
3.8.3 2023 Liposome Drug Delivery Tier 1, Tier 2, and Tier
4 LIPOSOME DRUG DELIVERY REGIONAL STATUS AND OUTLOOK
4.1 Global Liposome Drug Delivery Market Size and CAGR by Region: 2019 VS 2023 VS 2030
4.2 Global Liposome Drug Delivery Historic Market Size by Region
4.2.1 Global Liposome Drug Delivery Sales in Volume by Region (2019-2024)
4.2.2 Global Liposome Drug Delivery Sales in Value by Region (2019-2024)
4.2.3 Global Liposome Drug Delivery Sales (Volume & Value), Price and Gross Margin (2019-2024)
4.3 Global Liposome Drug Delivery Forecasted Market Size by Region
4.3.1 Global Liposome Drug Delivery Sales in Volume by Region (2025-2030)
4.3.2 Global Liposome Drug Delivery Sales in Value by Region (2025-2030)
4.3.3 Global Liposome Drug Delivery Sales (Volume & Value), Price and Gross Margin (2025-2030)
5 LIPOSOME DRUG DELIVERY BY APPLICATION
5.1 Liposome Drug Delivery Market by Application
5.1.1 Fungal Infection Therapy
5.1.2 Cancer & Tumor Therapy
5.1.3 Others
5.2 Global Liposome Drug Delivery Market Size by Application
5.2.1 Global Liposome Drug Delivery Market Size Overview by Application (2019-2030)
5.2.2 Global Liposome Drug Delivery Historic Market Size Review by Application (2019-2024)
5.2.3 Global Liposome Drug Delivery Forecasted Market Size by Application (2025-2030)
5.3 Key Regions Market Size by Application
5.3.1 North America Liposome Drug Delivery Sales Breakdown by Application (2019-2024)
5.3.2 Europe Liposome Drug Delivery Sales Breakdown by Application (2019-2024)
5.3.3 Asia-Pacific Liposome Drug Delivery Sales Breakdown by Application (2019-2024)
5.3.4 Latin America Liposome Drug Delivery Sales Breakdown by Application (2019-2024)
5.3.5 Middle East and Africa Liposome Drug Delivery Sales Breakdown by Application (2019-2024)
6 COMPANY PROFILES
6.1 Gilead Sciences
6.1.1 Gilead Sciences Comapny Information
6.1.2 Gilead Sciences Business Overview
6.1.3 Gilead Sciences Liposome Drug Delivery Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Gilead Sciences Liposome Drug Delivery Product Portfolio
6.1.5 Gilead Sciences Recent Developments
6.2 Pacira
6.2.1 Pacira Comapny Information
6.2.2 Pacira Business Overview
6.2.3 Pacira Liposome Drug Delivery Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Pacira Liposome Drug Delivery Product Portfolio
6.2.5 Pacira Recent Developments
6.3 Sun Pharmaceutical
6.3.1 Sun Pharmaceutical Comapny Information
6.3.2 Sun Pharmaceutical Business Overview
6.3.3 Sun Pharmaceutical Liposome Drug Delivery Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Sun Pharmaceutical Liposome Drug Delivery Product Portfolio
6.3.5 Sun Pharmaceutical Recent Developments
6.4 Johnson & Johnson
6.4.1 Johnson & Johnson Comapny Information
6.4.2 Johnson & Johnson Business Overview
6.4.3 Johnson & Johnson Liposome Drug Delivery Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Johnson & Johnson Liposome Drug Delivery Product Portfolio
6.4.5 Johnson & Johnson Recent Developments
6.5 Luye Pharma
6.5.1 Luye Pharma Comapny Information
6.5.2 Luye Pharma Business Overview
6.5.3 Luye Pharma Liposome Drug Delivery Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Luye Pharma Liposome Drug Delivery Product Portfolio
6.5.5 Luye Pharma Recent Developments
6.6 Sigma-Tau
6.6.1 Sigma-Tau Comapny Information
6.6.2 Sigma-Tau Business Overview
6.6.3 Sigma-Tau Liposome Drug Delivery Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Sigma-Tau Liposome Drug Delivery Product Portfolio
6.6.5 Sigma-Tau Recent Developments
6.7 Ipsen (Onivyde)
6.7.1 Ipsen (Onivyde) Comapny Information
6.7.2 Ipsen (Onivyde) Business Overview
6.7.3 Ipsen (Onivyde) Liposome Drug Delivery Sales, Revenue and Gross Margin (2019-2024)
6.7.4 Ipsen (Onivyde) Liposome Drug Delivery Product Portfolio
6.7.5 Ipsen (Onivyde) Recent Developments
6.8 CSPC
6.8.1 CSPC Comapny Information
6.8.2 CSPC Business Overview
6.8.3 CSPC Liposome Drug Delivery Sales, Revenue and Gross Margin (2019-2024)
6.8.4 CSPC Liposome Drug Delivery Product Portfolio
6.8.5 CSPC Recent Developments
6.9 Teva Pharmaceutical
6.9.1 Teva Pharmaceutical Comapny Information
6.9.2 Teva Pharmaceutical Business Overview
6.9.3 Teva Pharmaceutical Liposome Drug Delivery Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Teva Pharmaceutical Liposome Drug Delivery Product Portfolio
6.9.5 Teva Pharmaceutical Recent Developments
6.10 Novartis
6.10.1 Novartis Comapny Information
6.10.2 Novartis Business Overview
6.10.3 Novartis Liposome Drug Delivery Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Novartis Liposome Drug Delivery Product Portfolio
6.10.5 Novartis Recent Developments
6.11 Fudan-Zhangjiang
6.11.1 Fudan-Zhangjiang Comapny Information
6.11.2 Fudan-Zhangjiang Business Overview
6.11.3 Fudan-Zhangjiang Liposome Drug Delivery Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Fudan-Zhangjiang Liposome Drug Delivery Product Portfolio
6.11.5 Fudan-Zhangjiang Recent Developments
7 NORTH AMERICA BY COUNTRY
7.1 North America Liposome Drug Delivery Sales by Country
7.1.1 North America Liposome Drug Delivery Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
7.1.2 North America Liposome Drug Delivery Sales by Country (2019-2024)
7.1.3 North America Liposome Drug Delivery Sales Forecast by Country (2025-2030)
7.2 North America Liposome Drug Delivery Market Size by Country
7.2.1 North America Liposome Drug Delivery Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
7.2.2 North America Liposome Drug Delivery Market Size by Country (2019-2024)
7.2.3 North America Liposome Drug Delivery Market Size Forecast by Country (2025-2030)
8 EUROPE BY COUNTRY
8.1 Europe Liposome Drug Delivery Sales by Country
8.1.1 Europe Liposome Drug Delivery Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
8.1.2 Europe Liposome Drug Delivery Sales by Country (2019-2024)
8.1.3 Europe Liposome Drug Delivery Sales Forecast by Country (2025-2030)
8.2 Europe Liposome Drug Delivery Market Size by Country
8.2.1 Europe Liposome Drug Delivery Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
8.2.2 Europe Liposome Drug Delivery Market Size by Country (2019-2024)
8.2.3 Europe Liposome Drug Delivery Market Size Forecast by Country (2025-2030)
9 ASIA-PACIFIC BY COUNTRY
9.1 Asia-Pacific Liposome Drug Delivery Sales by Country
9.1.1 Asia-Pacific Liposome Drug Delivery Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
9.1.2 Asia-Pacific Liposome Drug Delivery Sales by Country (2019-2024)
9.1.3 Asia-Pacific Liposome Drug Delivery Sales Forecast by Country (2025-2030)
9.2 Asia-Pacific Liposome Drug Delivery Market Size by Country
9.2.1 Asia-Pacific Liposome Drug Delivery Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
9.2.2 Asia-Pacific Liposome Drug Delivery Market Size by Country (2019-2024)
9.2.3 Asia-Pacific Liposome Drug Delivery Market Size Forecast by Country (2025-2030)
10 LATIN AMERICA BY COUNTRY
10.1 Latin America Liposome Drug Delivery Sales by Country
10.1.1 Latin America Liposome Drug Delivery Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
10.1.2 Latin America Liposome Drug Delivery Sales by Country (2019-2024)
10.1.3 Latin America Liposome Drug Delivery Sales Forecast by Country (2025-2030)
10.2 Latin America Liposome Drug Delivery Market Size by Country
10.2.1 Latin America Liposome Drug Delivery Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
10.2.2 Latin America Liposome Drug Delivery Market Size by Country (2019-2024)
10.2.3 Latin America Liposome Drug Delivery Market Size Forecast by Country (2025-2030)
11 MIDDLE EAST AND AFRICA BY COUNTRY
11.1 Middle East and Africa Liposome Drug Delivery Sales by Country
11.1.1 Middle East and Africa Liposome Drug Delivery Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
11.1.2 Middle East and Africa Liposome Drug Delivery Sales by Country (2019-2024)
11.1.3 Middle East and Africa Liposome Drug Delivery Sales Forecast by Country (2025-2030)
11.2 Middle East and Africa Liposome Drug Delivery Market Size by Country
11.2.1 Middle East and Africa Liposome Drug Delivery Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
11.2.2 Middle East and Africa Liposome Drug Delivery Market Size by Country (2019-2024)
11.2.3 Middle East and Africa Liposome Drug Delivery Market Size Forecast by Country (2025-2030)
12 VALUE CHAIN AND SALES CHANNELS ANALYSIS
12.1 Liposome Drug Delivery Value Chain Analysis
12.1.1 Liposome Drug Delivery Key Raw Materials
12.1.2 Key Raw Materials Price
12.1.3 Raw Materials Key Suppliers
12.1.4 Manufacturing Cost Structure
12.1.5 Liposome Drug Delivery Production Mode & Process
12.2 Liposome Drug Delivery Sales Channels Analysis
12.2.1 Direct Comparison with Distribution Share
12.2.2 Liposome Drug Delivery Distributors
12.2.3 Liposome Drug Delivery Customers
13 CONCLUDING INSIGHTS
14 APPENDIX
14.1 Reasons for Doing This Study
14.2 Research Methodology
14.3 Research Process
14.4 Authors List of This Report
14.5 Data Source
14.5.1 Secondary Sources
14.5.2 Primary Sources
14.6 Disclaimer
1.1 Product Definition
1.2 Global Market Growth Prospects
1.2.1 Global Liposome Drug Delivery Market Size Estimates and Forecasts (2019-2030)
1.2.2 Global Liposome Drug Delivery Sales Estimates and Forecasts (2019-2030)
1.3 Liposome Drug Delivery Market by Type
1.3.1 Liposomal Doxorubicin
1.3.2 Liposomal Amphoteracin B
1.3.3 Liposomal Paclitaxel
1.3.4 Others
1.4 Global Liposome Drug Delivery Market Size by Type
1.4.1 Global Liposome Drug Delivery Market Size Overview by Type (2019-2030)
1.4.2 Global Liposome Drug Delivery Historic Market Size Review by Type (2019-2024)
1.4.3 Global Liposome Drug Delivery Forecasted Market Size by Type (2025-2030)
1.5 Key Regions Market Size by Type
1.5.1 North America Liposome Drug Delivery Sales Breakdown by Type (2019-2024)
1.5.2 Europe Liposome Drug Delivery Sales Breakdown by Type (2019-2024)
1.5.3 Asia-Pacific Liposome Drug Delivery Sales Breakdown by Type (2019-2024)
1.5.4 Latin America Liposome Drug Delivery Sales Breakdown by Type (2019-2024)
1.5.5 Middle East and Africa Liposome Drug Delivery Sales Breakdown by Type (2019-2024)
2 GLOBAL MARKET DYNAMICS
2.1 Liposome Drug Delivery Industry Trends
2.2 Liposome Drug Delivery Industry Drivers
2.3 Liposome Drug Delivery Industry Opportunities and Challenges
2.4 Liposome Drug Delivery Industry Restraints
3 MARKET COMPETITIVE LANDSCAPE BY COMPANY
3.1 Global Top Players by Liposome Drug Delivery Revenue (2019-2024)
3.2 Global Top Players by Liposome Drug Delivery Sales (2019-2024)
3.3 Global Top Players by Liposome Drug Delivery Price (2019-2024)
3.4 Global Liposome Drug Delivery Industry Company Ranking, 2022 VS 2023 VS 2024
3.5 Global Liposome Drug Delivery Key Company Manufacturing Sites & Headquarters
3.6 Global Liposome Drug Delivery Company, Product Type & Application
3.7 Global Liposome Drug Delivery Company Commercialization Time
3.8 Market Competitive Analysis
3.8.1 Global Liposome Drug Delivery Market CR5 and HHI
3.8.2 Global Top 5 and 10 Liposome Drug Delivery Players Market Share by Revenue in 2023
3.8.3 2023 Liposome Drug Delivery Tier 1, Tier 2, and Tier
4 LIPOSOME DRUG DELIVERY REGIONAL STATUS AND OUTLOOK
4.1 Global Liposome Drug Delivery Market Size and CAGR by Region: 2019 VS 2023 VS 2030
4.2 Global Liposome Drug Delivery Historic Market Size by Region
4.2.1 Global Liposome Drug Delivery Sales in Volume by Region (2019-2024)
4.2.2 Global Liposome Drug Delivery Sales in Value by Region (2019-2024)
4.2.3 Global Liposome Drug Delivery Sales (Volume & Value), Price and Gross Margin (2019-2024)
4.3 Global Liposome Drug Delivery Forecasted Market Size by Region
4.3.1 Global Liposome Drug Delivery Sales in Volume by Region (2025-2030)
4.3.2 Global Liposome Drug Delivery Sales in Value by Region (2025-2030)
4.3.3 Global Liposome Drug Delivery Sales (Volume & Value), Price and Gross Margin (2025-2030)
5 LIPOSOME DRUG DELIVERY BY APPLICATION
5.1 Liposome Drug Delivery Market by Application
5.1.1 Fungal Infection Therapy
5.1.2 Cancer & Tumor Therapy
5.1.3 Others
5.2 Global Liposome Drug Delivery Market Size by Application
5.2.1 Global Liposome Drug Delivery Market Size Overview by Application (2019-2030)
5.2.2 Global Liposome Drug Delivery Historic Market Size Review by Application (2019-2024)
5.2.3 Global Liposome Drug Delivery Forecasted Market Size by Application (2025-2030)
5.3 Key Regions Market Size by Application
5.3.1 North America Liposome Drug Delivery Sales Breakdown by Application (2019-2024)
5.3.2 Europe Liposome Drug Delivery Sales Breakdown by Application (2019-2024)
5.3.3 Asia-Pacific Liposome Drug Delivery Sales Breakdown by Application (2019-2024)
5.3.4 Latin America Liposome Drug Delivery Sales Breakdown by Application (2019-2024)
5.3.5 Middle East and Africa Liposome Drug Delivery Sales Breakdown by Application (2019-2024)
6 COMPANY PROFILES
6.1 Gilead Sciences
6.1.1 Gilead Sciences Comapny Information
6.1.2 Gilead Sciences Business Overview
6.1.3 Gilead Sciences Liposome Drug Delivery Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Gilead Sciences Liposome Drug Delivery Product Portfolio
6.1.5 Gilead Sciences Recent Developments
6.2 Pacira
6.2.1 Pacira Comapny Information
6.2.2 Pacira Business Overview
6.2.3 Pacira Liposome Drug Delivery Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Pacira Liposome Drug Delivery Product Portfolio
6.2.5 Pacira Recent Developments
6.3 Sun Pharmaceutical
6.3.1 Sun Pharmaceutical Comapny Information
6.3.2 Sun Pharmaceutical Business Overview
6.3.3 Sun Pharmaceutical Liposome Drug Delivery Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Sun Pharmaceutical Liposome Drug Delivery Product Portfolio
6.3.5 Sun Pharmaceutical Recent Developments
6.4 Johnson & Johnson
6.4.1 Johnson & Johnson Comapny Information
6.4.2 Johnson & Johnson Business Overview
6.4.3 Johnson & Johnson Liposome Drug Delivery Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Johnson & Johnson Liposome Drug Delivery Product Portfolio
6.4.5 Johnson & Johnson Recent Developments
6.5 Luye Pharma
6.5.1 Luye Pharma Comapny Information
6.5.2 Luye Pharma Business Overview
6.5.3 Luye Pharma Liposome Drug Delivery Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Luye Pharma Liposome Drug Delivery Product Portfolio
6.5.5 Luye Pharma Recent Developments
6.6 Sigma-Tau
6.6.1 Sigma-Tau Comapny Information
6.6.2 Sigma-Tau Business Overview
6.6.3 Sigma-Tau Liposome Drug Delivery Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Sigma-Tau Liposome Drug Delivery Product Portfolio
6.6.5 Sigma-Tau Recent Developments
6.7 Ipsen (Onivyde)
6.7.1 Ipsen (Onivyde) Comapny Information
6.7.2 Ipsen (Onivyde) Business Overview
6.7.3 Ipsen (Onivyde) Liposome Drug Delivery Sales, Revenue and Gross Margin (2019-2024)
6.7.4 Ipsen (Onivyde) Liposome Drug Delivery Product Portfolio
6.7.5 Ipsen (Onivyde) Recent Developments
6.8 CSPC
6.8.1 CSPC Comapny Information
6.8.2 CSPC Business Overview
6.8.3 CSPC Liposome Drug Delivery Sales, Revenue and Gross Margin (2019-2024)
6.8.4 CSPC Liposome Drug Delivery Product Portfolio
6.8.5 CSPC Recent Developments
6.9 Teva Pharmaceutical
6.9.1 Teva Pharmaceutical Comapny Information
6.9.2 Teva Pharmaceutical Business Overview
6.9.3 Teva Pharmaceutical Liposome Drug Delivery Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Teva Pharmaceutical Liposome Drug Delivery Product Portfolio
6.9.5 Teva Pharmaceutical Recent Developments
6.10 Novartis
6.10.1 Novartis Comapny Information
6.10.2 Novartis Business Overview
6.10.3 Novartis Liposome Drug Delivery Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Novartis Liposome Drug Delivery Product Portfolio
6.10.5 Novartis Recent Developments
6.11 Fudan-Zhangjiang
6.11.1 Fudan-Zhangjiang Comapny Information
6.11.2 Fudan-Zhangjiang Business Overview
6.11.3 Fudan-Zhangjiang Liposome Drug Delivery Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Fudan-Zhangjiang Liposome Drug Delivery Product Portfolio
6.11.5 Fudan-Zhangjiang Recent Developments
7 NORTH AMERICA BY COUNTRY
7.1 North America Liposome Drug Delivery Sales by Country
7.1.1 North America Liposome Drug Delivery Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
7.1.2 North America Liposome Drug Delivery Sales by Country (2019-2024)
7.1.3 North America Liposome Drug Delivery Sales Forecast by Country (2025-2030)
7.2 North America Liposome Drug Delivery Market Size by Country
7.2.1 North America Liposome Drug Delivery Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
7.2.2 North America Liposome Drug Delivery Market Size by Country (2019-2024)
7.2.3 North America Liposome Drug Delivery Market Size Forecast by Country (2025-2030)
8 EUROPE BY COUNTRY
8.1 Europe Liposome Drug Delivery Sales by Country
8.1.1 Europe Liposome Drug Delivery Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
8.1.2 Europe Liposome Drug Delivery Sales by Country (2019-2024)
8.1.3 Europe Liposome Drug Delivery Sales Forecast by Country (2025-2030)
8.2 Europe Liposome Drug Delivery Market Size by Country
8.2.1 Europe Liposome Drug Delivery Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
8.2.2 Europe Liposome Drug Delivery Market Size by Country (2019-2024)
8.2.3 Europe Liposome Drug Delivery Market Size Forecast by Country (2025-2030)
9 ASIA-PACIFIC BY COUNTRY
9.1 Asia-Pacific Liposome Drug Delivery Sales by Country
9.1.1 Asia-Pacific Liposome Drug Delivery Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
9.1.2 Asia-Pacific Liposome Drug Delivery Sales by Country (2019-2024)
9.1.3 Asia-Pacific Liposome Drug Delivery Sales Forecast by Country (2025-2030)
9.2 Asia-Pacific Liposome Drug Delivery Market Size by Country
9.2.1 Asia-Pacific Liposome Drug Delivery Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
9.2.2 Asia-Pacific Liposome Drug Delivery Market Size by Country (2019-2024)
9.2.3 Asia-Pacific Liposome Drug Delivery Market Size Forecast by Country (2025-2030)
10 LATIN AMERICA BY COUNTRY
10.1 Latin America Liposome Drug Delivery Sales by Country
10.1.1 Latin America Liposome Drug Delivery Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
10.1.2 Latin America Liposome Drug Delivery Sales by Country (2019-2024)
10.1.3 Latin America Liposome Drug Delivery Sales Forecast by Country (2025-2030)
10.2 Latin America Liposome Drug Delivery Market Size by Country
10.2.1 Latin America Liposome Drug Delivery Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
10.2.2 Latin America Liposome Drug Delivery Market Size by Country (2019-2024)
10.2.3 Latin America Liposome Drug Delivery Market Size Forecast by Country (2025-2030)
11 MIDDLE EAST AND AFRICA BY COUNTRY
11.1 Middle East and Africa Liposome Drug Delivery Sales by Country
11.1.1 Middle East and Africa Liposome Drug Delivery Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
11.1.2 Middle East and Africa Liposome Drug Delivery Sales by Country (2019-2024)
11.1.3 Middle East and Africa Liposome Drug Delivery Sales Forecast by Country (2025-2030)
11.2 Middle East and Africa Liposome Drug Delivery Market Size by Country
11.2.1 Middle East and Africa Liposome Drug Delivery Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
11.2.2 Middle East and Africa Liposome Drug Delivery Market Size by Country (2019-2024)
11.2.3 Middle East and Africa Liposome Drug Delivery Market Size Forecast by Country (2025-2030)
12 VALUE CHAIN AND SALES CHANNELS ANALYSIS
12.1 Liposome Drug Delivery Value Chain Analysis
12.1.1 Liposome Drug Delivery Key Raw Materials
12.1.2 Key Raw Materials Price
12.1.3 Raw Materials Key Suppliers
12.1.4 Manufacturing Cost Structure
12.1.5 Liposome Drug Delivery Production Mode & Process
12.2 Liposome Drug Delivery Sales Channels Analysis
12.2.1 Direct Comparison with Distribution Share
12.2.2 Liposome Drug Delivery Distributors
12.2.3 Liposome Drug Delivery Customers
13 CONCLUDING INSIGHTS
14 APPENDIX
14.1 Reasons for Doing This Study
14.2 Research Methodology
14.3 Research Process
14.4 Authors List of This Report
14.5 Data Source
14.5.1 Secondary Sources
14.5.2 Primary Sources
14.6 Disclaimer
LIST OF TABLES
Table 1. Major Company of Liposomal Doxorubicin
Table 2. Major Company of Liposomal Amphoteracin B
Table 3. Major Company of Liposomal Paclitaxel
Table 4. Major Company of Others
Table 5. Global Liposome Drug Delivery Sales by Type (2019 VS 2023 VS 2030) & (US$ Million)
Table 6. Global Liposome Drug Delivery Sales by Type (2019-2024) & (K Vial)
Table 7. Global Liposome Drug Delivery Sales Market Share in Volume by Type (2019-2024)
Table 8. Global Liposome Drug Delivery Sales by Type (2019-2024) & (US$ Million)
Table 9. Global Liposome Drug Delivery Sales Market Share in Value by Type (2019-2024)
Table 10. Global Liposome Drug Delivery Price by Type (2019-2024) & (USD/Vial)
Table 11. Global Liposome Drug Delivery Sales by Type (2025-2030) & (K Vial)
Table 12. Global Liposome Drug Delivery Sales Market Share in Volume by Type (2025-2030)
Table 13. Global Liposome Drug Delivery Sales by Type (2025-2030) & (US$ Million)
Table 14. Global Liposome Drug Delivery Sales Market Share in Value by Type (2025-2030)
Table 15. Global Liposome Drug Delivery Price by Type (2025-2030) & (USD/Vial)
Table 16. North America Liposome Drug Delivery Sales by Type (2019-2024) & (K Vial)
Table 17. North America Liposome Drug Delivery Sales by Type (2019-2024) & (US$ Million)
Table 18. Europe Liposome Drug Delivery Sales by Type (2019-2024) & (K Vial)
Table 19. Europe Liposome Drug Delivery Sales by Type (2019-2024) & (US$ Million)
Table 20. Asia-Pacific Liposome Drug Delivery Sales by Type (2019-2024) & (K Vial)
Table 21. Asia-Pacific Liposome Drug Delivery Sales by Type (2019-2024) & (US$ Million)
Table 22. Latin America Liposome Drug Delivery Sales by Type (2019-2024) & (K Vial)
Table 23. Latin America Liposome Drug Delivery Sales by Type (2019-2024) & (US$ Million)
Table 24. Middle East and Africa Liposome Drug Delivery Sales by Type (2019-2024) & (K Vial)
Table 25. Middle East and Africa Liposome Drug Delivery Sales by Type (2019-2024) & (US$ Million)
Table 26. Liposome Drug Delivery Industry Trends
Table 27. Liposome Drug Delivery Industry Drivers
Table 28. Liposome Drug Delivery Industry Opportunities and Challenges
Table 29. Liposome Drug Delivery Industry Restraints
Table 30. Global Liposome Drug Delivery Sales Revenue by Company (US$ Million) & (2019-2024)
Table 31. Global Liposome Drug Delivery Revenue Market Share by Company (2019-2024)
Table 32. Global Liposome Drug Delivery Sales by Company (2019-2024) & (K Vial)
Table 33. Global Liposome Drug Delivery Sales Share by Company (2019-2024)
Table 34. Global Liposome Drug Delivery Market Price by Company (2019-2024) & (USD/Vial)
Table 35. Global Liposome Drug Delivery Industry Company Ranking, 2022 VS 2023 VS 2024
Table 36. Global Liposome Drug Delivery Key Company Manufacturing Sites & Headquarters
Table 37. Global Liposome Drug Delivery Company, Product Type & Application
Table 38. Global Liposome Drug Delivery Company Commercialization Time
Table 39. Global Company Market Concentration Ratio (CR5 and HHI)
Table 40. Global Liposome Drug Delivery by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2023)
Table 41. Global Liposome Drug Delivery Market Size Comparison by Region (US$ Million): 2019 VS 2023 VS 2030
Table 42. Global Liposome Drug Delivery Sales by Region (2019-2024) & (K Vial)
Table 43. Global Liposome Drug Delivery Sales Market Share in Volume by Region (2019-2024)
Table 44. Global Liposome Drug Delivery Sales by Region (2019-2024) & (US$ Million)
Table 45. Global Liposome Drug Delivery Sales Market Share in Value by Region (2019-2024)
Table 46. Global Liposome Drug Delivery Sales (K Vial), Value (US$ Million), Price (USD/Vial) and Gross Margin (2019-2024)
Table 47. Global Liposome Drug Delivery Sales by Region (2025-2030) & (K Vial)
Table 48. Global Liposome Drug Delivery Sales Market Share in Volume by Region (2025-2030)
Table 49. Global Liposome Drug Delivery Sales by Region (2025-2030) & (US$ Million)
Table 50. Global Liposome Drug Delivery Sales Market Share in Value by Region (2025-2030)
Table 51. Global Liposome Drug Delivery Sales (K Vial), Value (US$ Million), Price (USD/Vial) and Gross Margin (2025-2030)
Table 52. Global Liposome Drug Delivery Sales by Application (2019 VS 2023 VS 2030) & (US$ Million)
Table 53. Global Liposome Drug Delivery Sales by Application (2019-2024) & (K Vial)
Table 54. Global Liposome Drug Delivery Sales Market Share in Volume by Application (2019-2024)
Table 55. Global Liposome Drug Delivery Sales by Application (2019-2024) & (US$ Million)
Table 56. Global Liposome Drug Delivery Sales Market Share in Value by Application (2019-2024)
Table 57. Global Liposome Drug Delivery Price by Application (2019-2024) & (USD/Vial)
Table 58. Global Liposome Drug Delivery Sales by Application (2025-2030) & (K Vial)
Table 59. Global Liposome Drug Delivery Sales Market Share in Volume by Application (2025-2030)
Table 60. Global Liposome Drug Delivery Sales by Application (2025-2030) & (US$ Million)
Table 61. Global Liposome Drug Delivery Sales Market Share in Value by Application (2025-2030)
Table 62. Global Liposome Drug Delivery Price by Application (2025-2030) & (USD/Vial)
Table 63. North America Liposome Drug Delivery Sales by Application (2019-2024) & (K Vial)
Table 64. North America Liposome Drug Delivery Sales by Application (2019-2024) & (US$ Million)
Table 65. Europe Liposome Drug Delivery Sales by Application (2019-2024) & (K Vial)
Table 66. Europe Liposome Drug Delivery Sales by Application (2019-2024) & (US$ Million)
Table 67. Asia-Pacific Liposome Drug Delivery Sales by Application (2019-2024) & (K Vial)
Table 68. Asia-Pacific Liposome Drug Delivery Sales by Application (2019-2024) & (US$ Million)
Table 69. Latin America Liposome Drug Delivery Sales by Application (2019-2024) & (K Vial)
Table 70. Latin America Liposome Drug Delivery Sales by Application (2019-2024) & (US$ Million)
Table 71. Middle East and Africa Liposome Drug Delivery Sales by Application (2019-2024) & (K Vial)
Table 72. Middle East and Africa Liposome Drug Delivery Sales by Application (2019-2024) & (US$ Million)
Table 73. Gilead Sciences Company Information
Table 74. Gilead Sciences Business Overview
Table 75. Gilead Sciences Liposome Drug Delivery Sales (K Vial), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2019-2024)
Table 76. Gilead Sciences Liposome Drug Delivery Product Portfolio
Table 77. Gilead Sciences Recent Development
Table 78. Pacira Company Information
Table 79. Pacira Business Overview
Table 80. Pacira Liposome Drug Delivery Sales (K Vial), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2019-2024)
Table 81. Pacira Liposome Drug Delivery Product Portfolio
Table 82. Pacira Recent Development
Table 83. Sun Pharmaceutical Company Information
Table 84. Sun Pharmaceutical Business Overview
Table 85. Sun Pharmaceutical Liposome Drug Delivery Sales (K Vial), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2019-2024)
Table 86. Sun Pharmaceutical Liposome Drug Delivery Product Portfolio
Table 87. Sun Pharmaceutical Recent Development
Table 88. Johnson & Johnson Company Information
Table 89. Johnson & Johnson Business Overview
Table 90. Johnson & Johnson Liposome Drug Delivery Sales (K Vial), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2019-2024)
Table 91. Johnson & Johnson Liposome Drug Delivery Product Portfolio
Table 92. Johnson & Johnson Recent Development
Table 93. Luye Pharma Company Information
Table 94. Luye Pharma Business Overview
Table 95. Luye Pharma Liposome Drug Delivery Sales (K Vial), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2019-2024)
Table 96. Luye Pharma Liposome Drug Delivery Product Portfolio
Table 97. Luye Pharma Recent Development
Table 98. Sigma-Tau Company Information
Table 99. Sigma-Tau Business Overview
Table 100. Sigma-Tau Liposome Drug Delivery Sales (K Vial), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2019-2024)
Table 101. Sigma-Tau Liposome Drug Delivery Product Portfolio
Table 102. Sigma-Tau Recent Development
Table 103. Ipsen (Onivyde) Company Information
Table 104. Ipsen (Onivyde) Business Overview
Table 105. Ipsen (Onivyde) Liposome Drug Delivery Sales (K Vial), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2019-2024)
Table 106. Ipsen (Onivyde) Liposome Drug Delivery Product Portfolio
Table 107. Ipsen (Onivyde) Recent Development
Table 108. CSPC Company Information
Table 109. CSPC Business Overview
Table 110. CSPC Liposome Drug Delivery Sales (K Vial), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2019-2024)
Table 111. CSPC Liposome Drug Delivery Product Portfolio
Table 112. CSPC Recent Development
Table 113. Teva Pharmaceutical Company Information
Table 114. Teva Pharmaceutical Business Overview
Table 115. Teva Pharmaceutical Liposome Drug Delivery Sales (K Vial), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2019-2024)
Table 116. Teva Pharmaceutical Liposome Drug Delivery Product Portfolio
Table 117. Teva Pharmaceutical Recent Development
Table 118. Novartis Company Information
Table 119. Novartis Business Overview
Table 120. Novartis Liposome Drug Delivery Sales (K Vial), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2019-2024)
Table 121. Novartis Liposome Drug Delivery Product Portfolio
Table 122. Novartis Recent Development
Table 123. Fudan-Zhangjiang Company Information
Table 124. Fudan-Zhangjiang Business Overview
Table 125. Fudan-Zhangjiang Liposome Drug Delivery Sales (K Vial), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2019-2024)
Table 126. Fudan-Zhangjiang Liposome Drug Delivery Product Portfolio
Table 127. Fudan-Zhangjiang Recent Development
Table 128. North America Liposome Drug Delivery Market Size Growth Rate (CAGR) by Country (K Vial): 2019 VS 2023 VS 2030
Table 129. North America Liposome Drug Delivery Sales by Country (2019-2024) & (K Vial)
Table 130. North America Liposome Drug Delivery Sales Market Share by Country (2019-2024)
Table 131. North America Liposome Drug Delivery Sales Forecast by Country (2025-2030) & (K Vial)
Table 132. North America Liposome Drug Delivery Sales Market Share Forecast by Country (2025-2030)
Table 133. North America Liposome Drug Delivery Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 134. North America Liposome Drug Delivery Market Size by Country (2019-2024) & (US$ Million)
Table 135. North America Liposome Drug Delivery Market Share by Country (2019-2024)
Table 136. North America Liposome Drug Delivery Market Size Forecast by Country (2025-2030) & (US$ Million)
Table 137. North America Liposome Drug Delivery Market Share Forecast by Country (2025-2030)
Table 138. Europe Liposome Drug Delivery Market Size Growth Rate (CAGR) by Country (K Vial): 2019 VS 2023 VS 2030
Table 139. Europe Liposome Drug Delivery Sales by Country (2019-2024) & (K Vial)
Table 140. Europe Liposome Drug Delivery Sales Market Share by Country (2019-2024)
Table 141. Europe Liposome Drug Delivery Sales Forecast by Country (2025-2030) & (K Vial)
Table 142. Europe Liposome Drug Delivery Sales Market Share Forecast by Country (2025-2030)
Table 143. Europe Liposome Drug Delivery Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 144. Europe Liposome Drug Delivery Market Size by Country (2019-2024) & (US$ Million)
Table 145. Europe Liposome Drug Delivery Market Share by Country (2019-2024)
Table 146. Europe Liposome Drug Delivery Market Size Forecast by Country (2025-2030) & (US$ Million)
Table 147. Europe Liposome Drug Delivery Market Share Forecast by Country (2025-2030)
Table 148. Asia-Pacific Liposome Drug Delivery Market Size Growth Rate (CAGR) by Country (K Vial): 2019 VS 2023 VS 2030
Table 149. Asia-Pacific Liposome Drug Delivery Sales by Country (2019-2024) & (K Vial)
Table 150. Asia-Pacific Liposome Drug Delivery Sales Market Share by Country (2019-2024)
Table 151. Asia-Pacific Liposome Drug Delivery Sales Forecast by Country (2025-2030) & (K Vial)
Table 152. Asia-Pacific Liposome Drug Delivery Sales Market Share Forecast by Country (2025-2030)
Table 153. Asia-Pacific Liposome Drug Delivery Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 154. Asia-Pacific Liposome Drug Delivery Market Size by Country (2019-2024) & (US$ Million)
Table 155. Asia-Pacific Liposome Drug Delivery Market Share by Country (2019-2024)
Table 156. Asia-Pacific Liposome Drug Delivery Market Size Forecast by Country (2025-2030) & (US$ Million)
Table 157. Asia-Pacific Liposome Drug Delivery Market Share Forecast by Country (2025-2030)
Table 158. Latin America Liposome Drug Delivery Market Size Growth Rate (CAGR) by Country (K Vial): 2019 VS 2023 VS 2030
Table 159. Latin America Liposome Drug Delivery Sales by Country (2019-2024) & (K Vial)
Table 160. Latin America Liposome Drug Delivery Sales Market Share by Country (2019-2024)
Table 161. Latin America Liposome Drug Delivery Sales Forecast by Country (2025-2030) & (K Vial)
Table 162. Latin America Liposome Drug Delivery Sales Market Share Forecast by Country (2025-2030)
Table 163. Latin America Liposome Drug Delivery Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 164. Latin America Liposome Drug Delivery Market Size by Country (2019-2024) & (US$ Million)
Table 165. Latin America Liposome Drug Delivery Market Share by Country (2019-2024)
Table 166. Latin America Liposome Drug Delivery Market Size Forecast by Country (2025-2030) & (US$ Million)
Table 167. Latin America Liposome Drug Delivery Market Share Forecast by Country (2025-2030)
Table 168. Middle East and Africa Liposome Drug Delivery Market Size Growth Rate (CAGR) by Country (K Vial): 2019 VS 2023 VS 2030
Table 169. Middle East and Africa Liposome Drug Delivery Sales by Country (2019-2024) & (K Vial)
Table 170. Middle East and Africa Liposome Drug Delivery Sales Market Share by Country (2019-2024)
Table 171. Middle East and Africa Liposome Drug Delivery Sales Forecast by Country (2025-2030) & (K Vial)
Table 172. Middle East and Africa Liposome Drug Delivery Sales Market Share Forecast by Country (2025-2030)
Table 173. Middle East and Africa Liposome Drug Delivery Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 174. Middle East and Africa Liposome Drug Delivery Market Size by Country (2019-2024) & (US$ Million)
Table 175. Middle East and Africa Liposome Drug Delivery Market Share by Country (2019-2024)
Table 176. Middle East and Africa Liposome Drug Delivery Market Size Forecast by Country (2025-2030) & (US$ Million)
Table 177. Middle East and Africa Liposome Drug Delivery Market Share Forecast by Country (2025-2030)
Table 178. Key Raw Materials
Table 179. Raw Materials Key Suppliers
Table 180. Liposome Drug Delivery Distributors List
Table 181. Liposome Drug Delivery Customers List
Table 182. Research Programs/Design for This Report
Table 183. Authors List of This Report
Table 184. Secondary Sources
Table 185. Primary Sources
Table 1. Major Company of Liposomal Doxorubicin
Table 2. Major Company of Liposomal Amphoteracin B
Table 3. Major Company of Liposomal Paclitaxel
Table 4. Major Company of Others
Table 5. Global Liposome Drug Delivery Sales by Type (2019 VS 2023 VS 2030) & (US$ Million)
Table 6. Global Liposome Drug Delivery Sales by Type (2019-2024) & (K Vial)
Table 7. Global Liposome Drug Delivery Sales Market Share in Volume by Type (2019-2024)
Table 8. Global Liposome Drug Delivery Sales by Type (2019-2024) & (US$ Million)
Table 9. Global Liposome Drug Delivery Sales Market Share in Value by Type (2019-2024)
Table 10. Global Liposome Drug Delivery Price by Type (2019-2024) & (USD/Vial)
Table 11. Global Liposome Drug Delivery Sales by Type (2025-2030) & (K Vial)
Table 12. Global Liposome Drug Delivery Sales Market Share in Volume by Type (2025-2030)
Table 13. Global Liposome Drug Delivery Sales by Type (2025-2030) & (US$ Million)
Table 14. Global Liposome Drug Delivery Sales Market Share in Value by Type (2025-2030)
Table 15. Global Liposome Drug Delivery Price by Type (2025-2030) & (USD/Vial)
Table 16. North America Liposome Drug Delivery Sales by Type (2019-2024) & (K Vial)
Table 17. North America Liposome Drug Delivery Sales by Type (2019-2024) & (US$ Million)
Table 18. Europe Liposome Drug Delivery Sales by Type (2019-2024) & (K Vial)
Table 19. Europe Liposome Drug Delivery Sales by Type (2019-2024) & (US$ Million)
Table 20. Asia-Pacific Liposome Drug Delivery Sales by Type (2019-2024) & (K Vial)
Table 21. Asia-Pacific Liposome Drug Delivery Sales by Type (2019-2024) & (US$ Million)
Table 22. Latin America Liposome Drug Delivery Sales by Type (2019-2024) & (K Vial)
Table 23. Latin America Liposome Drug Delivery Sales by Type (2019-2024) & (US$ Million)
Table 24. Middle East and Africa Liposome Drug Delivery Sales by Type (2019-2024) & (K Vial)
Table 25. Middle East and Africa Liposome Drug Delivery Sales by Type (2019-2024) & (US$ Million)
Table 26. Liposome Drug Delivery Industry Trends
Table 27. Liposome Drug Delivery Industry Drivers
Table 28. Liposome Drug Delivery Industry Opportunities and Challenges
Table 29. Liposome Drug Delivery Industry Restraints
Table 30. Global Liposome Drug Delivery Sales Revenue by Company (US$ Million) & (2019-2024)
Table 31. Global Liposome Drug Delivery Revenue Market Share by Company (2019-2024)
Table 32. Global Liposome Drug Delivery Sales by Company (2019-2024) & (K Vial)
Table 33. Global Liposome Drug Delivery Sales Share by Company (2019-2024)
Table 34. Global Liposome Drug Delivery Market Price by Company (2019-2024) & (USD/Vial)
Table 35. Global Liposome Drug Delivery Industry Company Ranking, 2022 VS 2023 VS 2024
Table 36. Global Liposome Drug Delivery Key Company Manufacturing Sites & Headquarters
Table 37. Global Liposome Drug Delivery Company, Product Type & Application
Table 38. Global Liposome Drug Delivery Company Commercialization Time
Table 39. Global Company Market Concentration Ratio (CR5 and HHI)
Table 40. Global Liposome Drug Delivery by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2023)
Table 41. Global Liposome Drug Delivery Market Size Comparison by Region (US$ Million): 2019 VS 2023 VS 2030
Table 42. Global Liposome Drug Delivery Sales by Region (2019-2024) & (K Vial)
Table 43. Global Liposome Drug Delivery Sales Market Share in Volume by Region (2019-2024)
Table 44. Global Liposome Drug Delivery Sales by Region (2019-2024) & (US$ Million)
Table 45. Global Liposome Drug Delivery Sales Market Share in Value by Region (2019-2024)
Table 46. Global Liposome Drug Delivery Sales (K Vial), Value (US$ Million), Price (USD/Vial) and Gross Margin (2019-2024)
Table 47. Global Liposome Drug Delivery Sales by Region (2025-2030) & (K Vial)
Table 48. Global Liposome Drug Delivery Sales Market Share in Volume by Region (2025-2030)
Table 49. Global Liposome Drug Delivery Sales by Region (2025-2030) & (US$ Million)
Table 50. Global Liposome Drug Delivery Sales Market Share in Value by Region (2025-2030)
Table 51. Global Liposome Drug Delivery Sales (K Vial), Value (US$ Million), Price (USD/Vial) and Gross Margin (2025-2030)
Table 52. Global Liposome Drug Delivery Sales by Application (2019 VS 2023 VS 2030) & (US$ Million)
Table 53. Global Liposome Drug Delivery Sales by Application (2019-2024) & (K Vial)
Table 54. Global Liposome Drug Delivery Sales Market Share in Volume by Application (2019-2024)
Table 55. Global Liposome Drug Delivery Sales by Application (2019-2024) & (US$ Million)
Table 56. Global Liposome Drug Delivery Sales Market Share in Value by Application (2019-2024)
Table 57. Global Liposome Drug Delivery Price by Application (2019-2024) & (USD/Vial)
Table 58. Global Liposome Drug Delivery Sales by Application (2025-2030) & (K Vial)
Table 59. Global Liposome Drug Delivery Sales Market Share in Volume by Application (2025-2030)
Table 60. Global Liposome Drug Delivery Sales by Application (2025-2030) & (US$ Million)
Table 61. Global Liposome Drug Delivery Sales Market Share in Value by Application (2025-2030)
Table 62. Global Liposome Drug Delivery Price by Application (2025-2030) & (USD/Vial)
Table 63. North America Liposome Drug Delivery Sales by Application (2019-2024) & (K Vial)
Table 64. North America Liposome Drug Delivery Sales by Application (2019-2024) & (US$ Million)
Table 65. Europe Liposome Drug Delivery Sales by Application (2019-2024) & (K Vial)
Table 66. Europe Liposome Drug Delivery Sales by Application (2019-2024) & (US$ Million)
Table 67. Asia-Pacific Liposome Drug Delivery Sales by Application (2019-2024) & (K Vial)
Table 68. Asia-Pacific Liposome Drug Delivery Sales by Application (2019-2024) & (US$ Million)
Table 69. Latin America Liposome Drug Delivery Sales by Application (2019-2024) & (K Vial)
Table 70. Latin America Liposome Drug Delivery Sales by Application (2019-2024) & (US$ Million)
Table 71. Middle East and Africa Liposome Drug Delivery Sales by Application (2019-2024) & (K Vial)
Table 72. Middle East and Africa Liposome Drug Delivery Sales by Application (2019-2024) & (US$ Million)
Table 73. Gilead Sciences Company Information
Table 74. Gilead Sciences Business Overview
Table 75. Gilead Sciences Liposome Drug Delivery Sales (K Vial), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2019-2024)
Table 76. Gilead Sciences Liposome Drug Delivery Product Portfolio
Table 77. Gilead Sciences Recent Development
Table 78. Pacira Company Information
Table 79. Pacira Business Overview
Table 80. Pacira Liposome Drug Delivery Sales (K Vial), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2019-2024)
Table 81. Pacira Liposome Drug Delivery Product Portfolio
Table 82. Pacira Recent Development
Table 83. Sun Pharmaceutical Company Information
Table 84. Sun Pharmaceutical Business Overview
Table 85. Sun Pharmaceutical Liposome Drug Delivery Sales (K Vial), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2019-2024)
Table 86. Sun Pharmaceutical Liposome Drug Delivery Product Portfolio
Table 87. Sun Pharmaceutical Recent Development
Table 88. Johnson & Johnson Company Information
Table 89. Johnson & Johnson Business Overview
Table 90. Johnson & Johnson Liposome Drug Delivery Sales (K Vial), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2019-2024)
Table 91. Johnson & Johnson Liposome Drug Delivery Product Portfolio
Table 92. Johnson & Johnson Recent Development
Table 93. Luye Pharma Company Information
Table 94. Luye Pharma Business Overview
Table 95. Luye Pharma Liposome Drug Delivery Sales (K Vial), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2019-2024)
Table 96. Luye Pharma Liposome Drug Delivery Product Portfolio
Table 97. Luye Pharma Recent Development
Table 98. Sigma-Tau Company Information
Table 99. Sigma-Tau Business Overview
Table 100. Sigma-Tau Liposome Drug Delivery Sales (K Vial), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2019-2024)
Table 101. Sigma-Tau Liposome Drug Delivery Product Portfolio
Table 102. Sigma-Tau Recent Development
Table 103. Ipsen (Onivyde) Company Information
Table 104. Ipsen (Onivyde) Business Overview
Table 105. Ipsen (Onivyde) Liposome Drug Delivery Sales (K Vial), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2019-2024)
Table 106. Ipsen (Onivyde) Liposome Drug Delivery Product Portfolio
Table 107. Ipsen (Onivyde) Recent Development
Table 108. CSPC Company Information
Table 109. CSPC Business Overview
Table 110. CSPC Liposome Drug Delivery Sales (K Vial), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2019-2024)
Table 111. CSPC Liposome Drug Delivery Product Portfolio
Table 112. CSPC Recent Development
Table 113. Teva Pharmaceutical Company Information
Table 114. Teva Pharmaceutical Business Overview
Table 115. Teva Pharmaceutical Liposome Drug Delivery Sales (K Vial), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2019-2024)
Table 116. Teva Pharmaceutical Liposome Drug Delivery Product Portfolio
Table 117. Teva Pharmaceutical Recent Development
Table 118. Novartis Company Information
Table 119. Novartis Business Overview
Table 120. Novartis Liposome Drug Delivery Sales (K Vial), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2019-2024)
Table 121. Novartis Liposome Drug Delivery Product Portfolio
Table 122. Novartis Recent Development
Table 123. Fudan-Zhangjiang Company Information
Table 124. Fudan-Zhangjiang Business Overview
Table 125. Fudan-Zhangjiang Liposome Drug Delivery Sales (K Vial), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2019-2024)
Table 126. Fudan-Zhangjiang Liposome Drug Delivery Product Portfolio
Table 127. Fudan-Zhangjiang Recent Development
Table 128. North America Liposome Drug Delivery Market Size Growth Rate (CAGR) by Country (K Vial): 2019 VS 2023 VS 2030
Table 129. North America Liposome Drug Delivery Sales by Country (2019-2024) & (K Vial)
Table 130. North America Liposome Drug Delivery Sales Market Share by Country (2019-2024)
Table 131. North America Liposome Drug Delivery Sales Forecast by Country (2025-2030) & (K Vial)
Table 132. North America Liposome Drug Delivery Sales Market Share Forecast by Country (2025-2030)
Table 133. North America Liposome Drug Delivery Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 134. North America Liposome Drug Delivery Market Size by Country (2019-2024) & (US$ Million)
Table 135. North America Liposome Drug Delivery Market Share by Country (2019-2024)
Table 136. North America Liposome Drug Delivery Market Size Forecast by Country (2025-2030) & (US$ Million)
Table 137. North America Liposome Drug Delivery Market Share Forecast by Country (2025-2030)
Table 138. Europe Liposome Drug Delivery Market Size Growth Rate (CAGR) by Country (K Vial): 2019 VS 2023 VS 2030
Table 139. Europe Liposome Drug Delivery Sales by Country (2019-2024) & (K Vial)
Table 140. Europe Liposome Drug Delivery Sales Market Share by Country (2019-2024)
Table 141. Europe Liposome Drug Delivery Sales Forecast by Country (2025-2030) & (K Vial)
Table 142. Europe Liposome Drug Delivery Sales Market Share Forecast by Country (2025-2030)
Table 143. Europe Liposome Drug Delivery Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 144. Europe Liposome Drug Delivery Market Size by Country (2019-2024) & (US$ Million)
Table 145. Europe Liposome Drug Delivery Market Share by Country (2019-2024)
Table 146. Europe Liposome Drug Delivery Market Size Forecast by Country (2025-2030) & (US$ Million)
Table 147. Europe Liposome Drug Delivery Market Share Forecast by Country (2025-2030)
Table 148. Asia-Pacific Liposome Drug Delivery Market Size Growth Rate (CAGR) by Country (K Vial): 2019 VS 2023 VS 2030
Table 149. Asia-Pacific Liposome Drug Delivery Sales by Country (2019-2024) & (K Vial)
Table 150. Asia-Pacific Liposome Drug Delivery Sales Market Share by Country (2019-2024)
Table 151. Asia-Pacific Liposome Drug Delivery Sales Forecast by Country (2025-2030) & (K Vial)
Table 152. Asia-Pacific Liposome Drug Delivery Sales Market Share Forecast by Country (2025-2030)
Table 153. Asia-Pacific Liposome Drug Delivery Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 154. Asia-Pacific Liposome Drug Delivery Market Size by Country (2019-2024) & (US$ Million)
Table 155. Asia-Pacific Liposome Drug Delivery Market Share by Country (2019-2024)
Table 156. Asia-Pacific Liposome Drug Delivery Market Size Forecast by Country (2025-2030) & (US$ Million)
Table 157. Asia-Pacific Liposome Drug Delivery Market Share Forecast by Country (2025-2030)
Table 158. Latin America Liposome Drug Delivery Market Size Growth Rate (CAGR) by Country (K Vial): 2019 VS 2023 VS 2030
Table 159. Latin America Liposome Drug Delivery Sales by Country (2019-2024) & (K Vial)
Table 160. Latin America Liposome Drug Delivery Sales Market Share by Country (2019-2024)
Table 161. Latin America Liposome Drug Delivery Sales Forecast by Country (2025-2030) & (K Vial)
Table 162. Latin America Liposome Drug Delivery Sales Market Share Forecast by Country (2025-2030)
Table 163. Latin America Liposome Drug Delivery Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 164. Latin America Liposome Drug Delivery Market Size by Country (2019-2024) & (US$ Million)
Table 165. Latin America Liposome Drug Delivery Market Share by Country (2019-2024)
Table 166. Latin America Liposome Drug Delivery Market Size Forecast by Country (2025-2030) & (US$ Million)
Table 167. Latin America Liposome Drug Delivery Market Share Forecast by Country (2025-2030)
Table 168. Middle East and Africa Liposome Drug Delivery Market Size Growth Rate (CAGR) by Country (K Vial): 2019 VS 2023 VS 2030
Table 169. Middle East and Africa Liposome Drug Delivery Sales by Country (2019-2024) & (K Vial)
Table 170. Middle East and Africa Liposome Drug Delivery Sales Market Share by Country (2019-2024)
Table 171. Middle East and Africa Liposome Drug Delivery Sales Forecast by Country (2025-2030) & (K Vial)
Table 172. Middle East and Africa Liposome Drug Delivery Sales Market Share Forecast by Country (2025-2030)
Table 173. Middle East and Africa Liposome Drug Delivery Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 174. Middle East and Africa Liposome Drug Delivery Market Size by Country (2019-2024) & (US$ Million)
Table 175. Middle East and Africa Liposome Drug Delivery Market Share by Country (2019-2024)
Table 176. Middle East and Africa Liposome Drug Delivery Market Size Forecast by Country (2025-2030) & (US$ Million)
Table 177. Middle East and Africa Liposome Drug Delivery Market Share Forecast by Country (2025-2030)
Table 178. Key Raw Materials
Table 179. Raw Materials Key Suppliers
Table 180. Liposome Drug Delivery Distributors List
Table 181. Liposome Drug Delivery Customers List
Table 182. Research Programs/Design for This Report
Table 183. Authors List of This Report
Table 184. Secondary Sources
Table 185. Primary Sources
LIST OF FIGURES
Figure 1. Liposome Drug Delivery Product Picture
Figure 2. Global Liposome Drug Delivery Market Size (US$ Million), 2019 VS 2023 VS 2030
Figure 3. Global Liposome Drug Delivery Market Size (2019-2030) & (US$ Million)
Figure 4. Global Liposome Drug Delivery Sales (2019-2030) & (K Vial)
Figure 5. Product Picture of Liposomal Doxorubicin
Figure 6. Global Liposomal Doxorubicin Sales YoY Growth (2019-2030) & (K Vial)
Figure 7. Product Picture of Liposomal Amphoteracin B
Figure 8. Global Liposomal Amphoteracin B Sales YoY Growth (2019-2030) & (K Vial)
Figure 9. Product Picture of Liposomal Paclitaxel
Figure 10. Global Liposomal Paclitaxel Sales YoY Growth (2019-2030) & (K Vial)
Figure 11. Product Picture of Others
Figure 12. Global Others Sales YoY Growth (2019-2030) & (K Vial)
Figure 13. Global Liposome Drug Delivery Market Size Overview by Type (2019-2030) & (US$ Million)
Figure 14. Global Liposome Drug Delivery Market Share by Type 2023 VS 2030
Figure 15. North America Liposome Drug Delivery Sales Market Share in Volume by Type in 2023
Figure 16. North America Liposome Drug Delivery Sales Market Share in Value by Type in 2023
Figure 17. Europe Liposome Drug Delivery Sales Market Share in Volume by Type in 2023
Figure 18. Europe Liposome Drug Delivery Sales Market Share in Value by Type in 2023
Figure 19. Asia-Pacific Liposome Drug Delivery Sales Market Share in Volume by Type in 2023
Figure 20. Asia-Pacific Liposome Drug Delivery Sales Market Share in Value by Type in 2023
Figure 21. Latin America Liposome Drug Delivery Sales Market Share in Volume by Type in 2023
Figure 22. Latin America Liposome Drug Delivery Sales Market Share in Value by Type in 2023
Figure 23. Middle East and Africa Liposome Drug Delivery Sales Market Share in Volume by Type in 2023
Figure 24. Middle East and Africa Liposome Drug Delivery Sales Market Share in Value by Type in 2023
Figure 25. Global Top 5 and 10 Liposome Drug Delivery Players Market Share by Revenue in 2023
Figure 26. Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 27. Product Picture of Fungal Infection Therapy
Figure 28. Global Fungal Infection Therapy Sales YoY Growth (2019-2030) & (K Vial)
Figure 29. Product Picture of Cancer & Tumor Therapy
Figure 30. Global Cancer & Tumor Therapy Sales YoY Growth (2019-2030) & (K Vial)
Figure 31. Product Picture of Others
Figure 32. Global Others Sales YoY Growth (2019-2030) & (K Vial)
Figure 33. Global Liposome Drug Delivery Market Size Overview by Application (2019-2030) & (US$ Million)
Figure 34. Global Liposome Drug Delivery Market Share by Application 2023 VS 2030
Figure 35. North America Liposome Drug Delivery Sales Market Share in Volume by Application in 2023
Figure 36. North America Liposome Drug Delivery Sales Market Share in Value by Application in 2023
Figure 37. Europe Liposome Drug Delivery Sales Market Share in Volume by Application in 2023
Figure 38. Europe Liposome Drug Delivery Sales Market Share in Value by Application in 2023
Figure 39. Asia-Pacific Liposome Drug Delivery Sales Market Share in Volume by Application in 2023
Figure 40. Asia-Pacific Liposome Drug Delivery Sales Market Share in Value by Application in 2023
Figure 41. Latin America Liposome Drug Delivery Sales Market Share in Volume by Application in 2023
Figure 42. Latin America Liposome Drug Delivery Sales Market Share in Value by Application in 2023
Figure 43. Middle East and Africa Liposome Drug Delivery Sales Market Share in Volume by Application in 2023
Figure 44. Middle East and Africa Liposome Drug Delivery Sales Market Share in Value by Application in 2023
Figure 45. North America Liposome Drug Delivery Sales by Country: 2019 VS 2023 VS 2030 (K Vial)
Figure 46. North America Liposome Drug Delivery Sales Share by Country: 2019 VS 2023 VS 2030
Figure 47. North America Liposome Drug Delivery Market Size by Country: 2019 VS 2023 VS 2030 (US$ Million)
Figure 48. North America Liposome Drug Delivery Market Share by Country: 2019 VS 2023 VS 2030
Figure 49. Europe Liposome Drug Delivery Sales by Country: 2019 VS 2023 VS 2030 (K Vial)
Figure 50. Europe Liposome Drug Delivery Sales Share by Country: 2019 VS 2023 VS 2030
Figure 51. Europe Liposome Drug Delivery Market Size by Country: 2019 VS 2023 VS 2030 (US$ Million)
Fig
Figure 1. Liposome Drug Delivery Product Picture
Figure 2. Global Liposome Drug Delivery Market Size (US$ Million), 2019 VS 2023 VS 2030
Figure 3. Global Liposome Drug Delivery Market Size (2019-2030) & (US$ Million)
Figure 4. Global Liposome Drug Delivery Sales (2019-2030) & (K Vial)
Figure 5. Product Picture of Liposomal Doxorubicin
Figure 6. Global Liposomal Doxorubicin Sales YoY Growth (2019-2030) & (K Vial)
Figure 7. Product Picture of Liposomal Amphoteracin B
Figure 8. Global Liposomal Amphoteracin B Sales YoY Growth (2019-2030) & (K Vial)
Figure 9. Product Picture of Liposomal Paclitaxel
Figure 10. Global Liposomal Paclitaxel Sales YoY Growth (2019-2030) & (K Vial)
Figure 11. Product Picture of Others
Figure 12. Global Others Sales YoY Growth (2019-2030) & (K Vial)
Figure 13. Global Liposome Drug Delivery Market Size Overview by Type (2019-2030) & (US$ Million)
Figure 14. Global Liposome Drug Delivery Market Share by Type 2023 VS 2030
Figure 15. North America Liposome Drug Delivery Sales Market Share in Volume by Type in 2023
Figure 16. North America Liposome Drug Delivery Sales Market Share in Value by Type in 2023
Figure 17. Europe Liposome Drug Delivery Sales Market Share in Volume by Type in 2023
Figure 18. Europe Liposome Drug Delivery Sales Market Share in Value by Type in 2023
Figure 19. Asia-Pacific Liposome Drug Delivery Sales Market Share in Volume by Type in 2023
Figure 20. Asia-Pacific Liposome Drug Delivery Sales Market Share in Value by Type in 2023
Figure 21. Latin America Liposome Drug Delivery Sales Market Share in Volume by Type in 2023
Figure 22. Latin America Liposome Drug Delivery Sales Market Share in Value by Type in 2023
Figure 23. Middle East and Africa Liposome Drug Delivery Sales Market Share in Volume by Type in 2023
Figure 24. Middle East and Africa Liposome Drug Delivery Sales Market Share in Value by Type in 2023
Figure 25. Global Top 5 and 10 Liposome Drug Delivery Players Market Share by Revenue in 2023
Figure 26. Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 27. Product Picture of Fungal Infection Therapy
Figure 28. Global Fungal Infection Therapy Sales YoY Growth (2019-2030) & (K Vial)
Figure 29. Product Picture of Cancer & Tumor Therapy
Figure 30. Global Cancer & Tumor Therapy Sales YoY Growth (2019-2030) & (K Vial)
Figure 31. Product Picture of Others
Figure 32. Global Others Sales YoY Growth (2019-2030) & (K Vial)
Figure 33. Global Liposome Drug Delivery Market Size Overview by Application (2019-2030) & (US$ Million)
Figure 34. Global Liposome Drug Delivery Market Share by Application 2023 VS 2030
Figure 35. North America Liposome Drug Delivery Sales Market Share in Volume by Application in 2023
Figure 36. North America Liposome Drug Delivery Sales Market Share in Value by Application in 2023
Figure 37. Europe Liposome Drug Delivery Sales Market Share in Volume by Application in 2023
Figure 38. Europe Liposome Drug Delivery Sales Market Share in Value by Application in 2023
Figure 39. Asia-Pacific Liposome Drug Delivery Sales Market Share in Volume by Application in 2023
Figure 40. Asia-Pacific Liposome Drug Delivery Sales Market Share in Value by Application in 2023
Figure 41. Latin America Liposome Drug Delivery Sales Market Share in Volume by Application in 2023
Figure 42. Latin America Liposome Drug Delivery Sales Market Share in Value by Application in 2023
Figure 43. Middle East and Africa Liposome Drug Delivery Sales Market Share in Volume by Application in 2023
Figure 44. Middle East and Africa Liposome Drug Delivery Sales Market Share in Value by Application in 2023
Figure 45. North America Liposome Drug Delivery Sales by Country: 2019 VS 2023 VS 2030 (K Vial)
Figure 46. North America Liposome Drug Delivery Sales Share by Country: 2019 VS 2023 VS 2030
Figure 47. North America Liposome Drug Delivery Market Size by Country: 2019 VS 2023 VS 2030 (US$ Million)
Figure 48. North America Liposome Drug Delivery Market Share by Country: 2019 VS 2023 VS 2030
Figure 49. Europe Liposome Drug Delivery Sales by Country: 2019 VS 2023 VS 2030 (K Vial)
Figure 50. Europe Liposome Drug Delivery Sales Share by Country: 2019 VS 2023 VS 2030
Figure 51. Europe Liposome Drug Delivery Market Size by Country: 2019 VS 2023 VS 2030 (US$ Million)
Fig
